Literature DB >> 23397354

Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes.

Osman David Mansoor1, Debra Kristensen, Andrew Meek, Simona Zipursky, Olga Popova, Olga Popovaa, InderJit Sharma, Gisele Miranda, Jules Millogo, Heidi Lasher.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23397354      PMCID： PMC3537252          DOI： 10.2471/BLT.12.110700

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  12 in total

1.  Frequency and causes of vaccine wastage.

Authors:  Sabeena Setia; Hugh Mainzer; Michael L Washington; Gary Coil; Robert Snyder; Bruce G Weniger
Journal:  Vaccine       Date:  2002-01-15       Impact factor: 3.641

2.  The privilege and responsibility of having choices: decision-making for new vaccines in developing countries.

Authors:  Carsten Mantel; Susan A Wang
Journal:  Health Policy Plan       Date:  2012-05       Impact factor: 3.344

3.  Health worker shortage could derail development goals.

Authors:  Clare Nullis-Kapp
Journal:  Bull World Health Organ       Date:  2005-01-21       Impact factor: 9.408

4.  Preventing cold chain failure: vaccine storage and handling.

Authors:  Erica Weir; Kathy Hatch
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

Review 5.  Freezing temperatures in the vaccine cold chain: a systematic literature review.

Authors:  Dipika M Matthias; Joanie Robertson; Michelle M Garrison; Sophie Newland; Carib Nelson
Journal:  Vaccine       Date:  2007-03-07       Impact factor: 3.641

6.  Global shortage of health workers, brain drain stress developing countries.

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2007-10-24       Impact factor: 56.272

7.  Vaccination: rattling the supply chain.

Authors:  Gary Humphreys
Journal:  Bull World Health Organ       Date:  2011-05-01       Impact factor: 9.408

8.  Exposure to heat and freezing in the vaccine cold chain in Thailand.

Authors:  Sirirat Techathawat; Porpit Varinsathien; Aimorn Rasdjarmrearnsook; Piyanit Tharmaphornpilas
Journal:  Vaccine       Date:  2006-10-18       Impact factor: 3.641

9.  Ensuring vaccine safety in immunization programmes--a WHO perspective.

Authors:  L Jodar; P Duclos; J B Milstien; E Griffiths; M T Aguado; C J Clements
Journal:  Vaccine       Date:  2001-02-08       Impact factor: 3.641

Review 10.  Technologies that make administration of vaccines safer.

Authors:  C John Clements; Gordon Larsen; Luis Jodar
Journal:  Vaccine       Date:  2004-05-07       Impact factor: 3.641
View more
  5 in total

1.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

2.  COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps.

Authors:  Jeffrey V Lazarus; Salim S Abdool Karim; Lena van Selm; Jason Doran; Carolina Batista; Yanis Ben Amor; Margaret Hellard; Booyuel Kim; Christopher J Kopka; Prashant Yadav
Journal:  BMJ Glob Health       Date:  2022-04

3.  Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine.

Authors:  Ahd Hamidi; Femke Hoeksema; Pim Velthof; Angelique Lemckert; Gert Gillissen; Alfred Luitjens; Julie E Bines; Swathi R Pullagurla; Prashant Kumar; David B Volkin; Sangeeta B Joshi; Menzo Havenga; Wilfried A M Bakker; Christopher Yallop
Journal:  Vaccine       Date:  2021-03-18       Impact factor: 3.641

4.  A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India.

Authors:  Raches Ella; Radhika Bobba; Sanjay Muralidhar; Sudhir Babji; Krishna Mohan Vadrevu; Maharaj Kishan Bhan
Journal:  Hum Vaccin Immunother       Date:  2018-04-12       Impact factor: 3.452

Review 5.  The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats.

Authors:  Michael Osterholm; Kristine Moore; Julie Ostrowsky; Kathleen Kimball-Baker; Jeremy Farrar
Journal:  Lancet Infect Dis       Date:  2015-10-30       Impact factor: 25.071
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.